Glaxosmithkline Share News (GSK)

Tuesday share tips: Sky, BG Group, Vodafone

Sky´s decision to dedicate one of its channels solely to Formula 1 fits in well with its strategy as a content distributor, but a theoretical purchase of the franchise whole does not. Speculation has surfaced it might do just that, with Liberty Global and a group backed by the Qatari government also

Broker tips: GlaxoSmithKline, Astrazeneca, Hikma, Shire, Petrofac, ARM Holdings

HSBC initiated coverage of the European pharmaceuticals, saying the re-rating over the last few years looks set to continue. In terms of UK stocks, it initiated GlaxoSmithKline at 'buy' with a 1,700p price target, and AstraZeneca and Hikma Pharmaceuticals at 'hold' with 4,640p and 1,936p price targe

Liberum upgrades GlaxoSmithKline to 'hold'

Liberum upgraded GlaxoSmithKline to 'hold' from 'sell', but cut the price target to 1,350p from 1,400p. "Somewhat counter-intuitively, we believe a dividend cut is increasingly likely and necessary and therefore we upgrade," said Liberum. "With the recent fall in the share and the increasing likeli

Friday broker round-up

ARM Holdings: Bernstein downgrades to underperform. GlaxoSmithKline: Liberum ups view to hold from sell. HSBC initiates coverage at buy with 1,700p target. AztraZeneca: HSBC initiates coverage at hold with 4,640p target. Qinetiq: UBS downgrades to sell from neutral. Meggitt: UBS raises view to ne

BROKER RATINGS SUMMARY: Bernstein Cuts ARM Holdings To Underperform

HSBC initiates coverage of European pharmaceuticals Astra, GSK, Hikma and Shire

HSBC initiated coverage of the European pharmaceuticals, saying the re-rating over the last few years looks set to continue. Although some pharma companies, such as AstraZeneca, still face generic pressure for drugs that contribute significantly to their top and bottom lines, the majority are largel

LONDON BRIEFING: Tesco Slows Sales Decline, Lifts Supermarket Stocks

Scientists crack gene secret that lets poppies make morphine

By Ben Hirschler LONDON, June 25 (Reuters) - Scientists have identified a key gene used by poppies to make morphine, paving the way for better methods of producing the medically important drug, potentially without the need for cultivating poppy fields. The latest finding follows rece

Boris Johnson to suggest creating a "megafund" for biotech firms

London mayor Boris Johnson on Thursday suggested that banks, investors and drug multinationals should condier creating a £10bn "megafund" to help biotech firms in the country to compete with US rivals. Johnson made the suggestion on the occasion of a conference in London that brought together the le

London mayor suggests $15 bln 'megafund' to boost biotech

LONDON, June 25 (Reuters) - Banks, investors and big drug companies should consider creating a 10-billion-pound ($15.7 billion) "megafund" to help biotech firms in London and across Britain compete with U.S. rivals, London mayor Boris Johnson said on Thursday. Britain is a leader in academi

U.S. CDC updates recommendation for new meningitis B vaccines

June 24 (Reuters) - The U.S. Centers for Disease Control and Prevention on Wednesday recommended that decisions to use new meningitis B vaccines from Pfizer and GlaxoSmithKline in people aged 16 to 23 be made on an individual patient basis by physicians, the companies said, potentially paving th

GSK to sell meningitis vaccines to Pfizer Ireland

GlaxoSmithKline said on Monday that it is selling its meningitis vaccines Nimenrix and Mencevax to Pfizer Ireland Pharmaceuticals - a subsidiary of Pfizer Inc - for €115m. The sale follows commitments given to the European Commission and other regulators in connection with the merger control cleara

GSK sells two vaccines to Pfizer to ease competition concerns

LONDON, June 22 (Reuters) - GlaxoSmithKline has agreed to sell two meningitis vaccines to Pfizer to satisfy antitrust concerns after its recent acquisition of vaccines business of Novartis. The British drugmaker said on Monday that the total consideration for the sale of its Nimenrix and Me

GlaxoSmithKline To Sell Two Meningitis Vaccines To Pfizer Ireland

UK investigator says Chinese officials mistreated him to get GSK confession

LONDON/BEIJING, June 18 (Reuters) - A British corporate investigator freed from a Chinese jail last week has accused officials there of deliberately withholding medical treatment to try to force him to confess to a role in a scandal involving drugmaker GlaxoSmithKline Plc (GSK). Peter Humph